Picher-Martel Vincent, Locascio Joseph J, Chuang Kathy, David William S, Amato Anthony A, Gonzalez-Perez Paloma
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA02114, United States; Department of Neurology, Brigham Women's Hospital, Harvard Medical School, Boston, MA02115, United States.
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA02114, United States; Harvard Catalyst Biostatistical Consulting Group, Boston MA02114, United States.
Neuromuscul Disord. 2025 Feb;47:105255. doi: 10.1016/j.nmd.2024.105255. Epub 2024 Nov 26.
We aimed at investigating the presence of patterns that account for the phenotypic variability in a myotonic dystrophy type 2 (DM2) retrospective cohort at the Mass General Brigham Neuromuscular Centers. We collected the presence or absence of 23 clinical variables at symptom onset and diagnosis (n = 67 patients) and follow-up (n = 37 patients). We first identified set/s of variables (factors or cluster/s) representative of the large research data pool at onset by performing factor analyses, then assigned each patient to the cluster for which they had the highest computed total factor score. Twelve variables grouped into two distinct clusters that, based on their variable content, we named as proximal myotonic myopathy (PROMM)-DM2 or non-PROMM-DM2. Patients assigned to non-PROMM-DM2 more frequently had clinical myotonia and positive family history, and less frequently multiorgan involvement. Most patients (67.2 %) remained assigned to same cluster during disease course and 11 non-PROMM eventually transitioned to PROMM-DM2. Dyslipidemia and early cataracts (both in PROMM-DM2 cluster) were the earliest extramuscular manifestations that occurred during disease course and they accounted for the conversion of up to 8 out of 11 non-PROMM to PROMM converters. Identification of phenotypically homogeneous patient subgroups may help investigating DM2 prognosis and disease biomarkers in future prospective studies.
我们旨在调查在麻省总医院布莱根妇女医院神经肌肉中心的2型强直性肌营养不良(DM2)回顾性队列中,能够解释表型变异性的模式的存在情况。我们收集了67例患者症状发作和诊断时以及37例患者随访时23项临床变量的有无情况。我们首先通过进行因子分析,在发病时识别出代表大型研究数据池的变量集(因素或聚类),然后将每位患者分配到其计算出的总因子得分最高的聚类中。12个变量分为两个不同的聚类,根据其变量内容,我们将其命名为近端强直性肌病(PROMM)-DM2或非PROMM-DM2。被分配到非PROMM-DM2的患者临床肌强直和家族史阳性更为常见,多器官受累则较少见。大多数患者(67.2%)在病程中仍被分配到同一聚类,11例非PROMM患者最终转变为PROMM-DM2。血脂异常和早期白内障(均在PROMM-DM2聚类中)是病程中最早出现的肌肉外表现,它们占11例非PROMM转变为PROMM患者中的8例。识别表型同质的患者亚组可能有助于在未来的前瞻性研究中调查DM2的预后和疾病生物标志物。